Mkts

Medpace Holdings, Inc.

NASDAQ: MEDP
$669.20+15.23 (+2.33%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
645.93670.18
52-week range
373.00684.52
Today
Open654.98
Previous close669.20
Volume—
Valuation
Market cap18.68B
P/E ratio38.00×
EPS (TTM)17.05
Income & risk
Dividend / yield—
Beta1.11
Avg volume303.4K
Discussion

MEDP News

Stories mentioning MEDP from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue706,604708,450659,903603,311558,570536,589533,317528,104
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development
Sales General & Admin47,91744,91648,08246,66457,89745,43349,21741,453
Total Operating Expenses
Operating Income (Loss)141,503153,269141,808126,335113,523125,378112,273105,150
Interest Income
Interest Expense
Other Expense971.00(158.00)(489.00)(2,875)(1,816)621.00(1,025)(133.00)
Pretax Income147,591156,833142,836124,538118,170133,882118,776110,482
Tax Provision23,72121,70031,70134,2783,57516,86422,35022,131
Net Income (Loss)123,870135,133111,13590,260114,595117,01896,42688,351
Earnings Per Share (Basic)4.354.683.953.163.773.783.112.85
Earnings Per Share (Diluted)4.284.583.863.103.673.663.012.75
Weighted Average Shares Outstanding (Basic)28,44528,84628,13628,60130,38730,95731,04730,990
Weighted Average Shares Outstanding (Diluted)28,96229,52728,81729,14331,19632,01432,08832,086

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MEDP

Medpace Holdings, Inc. (NASDAQ: MEDP) is a stock listed on the Nasdaq Stock Market under the ticker symbol MEDP. It last traded at $669.20 (Oct 23, 2026, 4:00 PM ET), up 2.3% on the day. That gives Medpace a market capitalisation of $18.7B and a price-to-earnings ratio of 38.0.

Over the past 52 weeks MEDP has traded between $373.00 and $684.52.

Revenue for the quarter ended Mar 31, 2026 was $706.6M; net income $123.9M. Revenue was up 26.5% from $558.6M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$706.6M$123.9M17.5%
Dec 31, 2025$708.5M$135.1M19.1%
Sep 30, 2025$659.9M$111.1M16.8%
Jun 30, 2025$603.3M$90.3M15.0%

From Medpace’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…